INZY

Inozyme Pharma
INZY

Overview Fund Activity
Delisted

INZY was delisted on the 30th of June, 2025.

Back to rankings

84 hedge funds and large institutions have $189M invested in Inozyme Pharma in 2025 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 8 increasing their positions, 29 reducing their positions, and 47 closing their positions.

Holders
84
Holders Change
-13
Holders Change %
-13.4%
% of All Funds
1.13%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.04%
New
35
Increased
8
Reduced
29
Closed
47
Calls
$695K
Puts
–
Net Calls
+$695K
Net Calls Change
+$683K

Top Buyers

1
BCM
1
Beryl Capital Management
California
$25.3M
2
GCL
2
Glazer Capital LLC
New York
$17.3M
3
TC
3
Trium Capital
United Kingdom
$12.7M
4
AAM
4
Alpine Associates Management
Florida
$8.75M
5
GF
5
Gabelli Funds
New York
$5.83M

Top Sellers

1
AAA
1
Affinity Asset Advisors
New York
$7M
2
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$0
3
Fidelity Investments
3
Fidelity Investments
Massachusetts
$79.8K
4
BlackRock
4
BlackRock
New York
$10.7M
5
RSCM
5
Rock Springs Capital Management
Maryland
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Osaic Holdings
126
Osaic Holdings
Arizona
– – -2,217 Closed
AB
127
Amalgamated Bank
New York
– – -1,676 Closed
SCM
128
Sterling Capital Management
North Carolina
– – -924 Closed
S
129
Sachetta
Massachusetts
– – -100 Closed
TWD
130
True Wealth Design
Ohio
– – -67 Closed
RIL
131
Rothschild Investment LLC
Illinois
– – -45 Closed
2 3 4 5
6